Clinical trials
Gastrointestinal Stromal Tumors trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Terminated | 3 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 7 |
| Deciphera Pharmaceuticals, LLC | 4 |
| Pfizer | 3 |
| Bayer | 2 |
| Blueprint Medicines Corporation | 2 |
| GlaxoSmithKline | 2 |
| Grupo Espanol de Investigacion en Sarcomas | 2 |
| Aesculap AG | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| Cogent Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Stromal Tumors | 31 |
| Neoplasm Metastasis | 5 |
| Breast Neoplasms | 4 |
| Gastrointestinal Neoplasms | 4 |
| Biliary Tract Neoplasms | 3 |
| Carcinoma, Hepatocellular | 3 |
| Ovarian Neoplasms | 3 |
| Sarcoma | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colorectal Neoplasms | 2 |
Trials
Showing 76 to 31 of 31. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.